Literature DB >> 13488318

Radiolabeled antibodies.

D PRESSMAN.   

Abstract

Keywords:  ANTIBODIES; NEOPLASMS/immunology

Mesh：

Substances：

Year:  1957        PMID： 13488318     DOI： 10.1111/j.1749-6632.1957.tb49702.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  9 in total

1.  Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma.

Authors:  Steven I Park; Jaideep Shenoi; Shani M Frayo; Donald K Hamlin; Yukang Lin; D Scott Wilbur; Patrick S Stayton; Nural Orgun; Mark Hylarides; Franz Buchegger; Aimee L Kenoyer; Amanda Axtman; Ajay K Gopal; Damian J Green; John M Pagel; Oliver W Press
Journal:  Clin Cancer Res       Date:  2011-10-05       Impact factor: 12.531

2.  Radioimmunotechnology for cancer diagnosis and treatment.

Authors:  S Holt; B M Longenecker; A A Noujaim
Journal:  Can Med Assoc J       Date:  1983-07-01       Impact factor: 8.262

3.  Pharmacokinetic study of radiolabeled anti-colorectal carcinoma monoclonal antibodies in tumor-bearing nude mice.

Authors:  J Y Douillard; J F Chatal; J C Saccavini; C Curtet; M Kremer; P Peuvrel; H Koprowski
Journal:  Eur J Nucl Med       Date:  1985

4.  Scintigraphy and distribution of labeled antibodies in rats with tumors.

Authors:  J G Sharp; J W Osborne; H F Cheng; K L Coop; G R Zimmerman
Journal:  Eur J Nucl Med       Date:  1982

5.  Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen.

Authors:  P W Dykes; K R Hine; A R Bradwell; J C Blackburn; T A Reeder; Z Drolc; S N Booth
Journal:  Br Med J       Date:  1980-01-26

6.  Effect of dose escalation of a monoclonal anti-CEA IgG on tumour localisation and tissue distribution in nude mice xenografted with human colon carcinoma.

Authors:  G T Rogers; R B Pedley; J Boden; P J Harwood; K D Bagshawe
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

7.  Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin. Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion.

Authors:  Z Fan; Z Tang; K Liu; D Zhou; J Lu; A Yuan; H Zhao
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

8.  Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody.

Authors:  A F Saiful Alam
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

9.  Localization of human breast-carcinoma xenografts using antibodies to carcinoembryonic antigen.

Authors:  V Moshakis; M J Bailey; M G Ormerod; J H Westwood; A M Neville
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.